Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Protalix Biotherapeutics Inc PLX

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also... see more

Current News (NYSEAM:PLX)

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

ACCESS Newswire November 9, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

ACCESS Newswire November 8, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

ACCESS Newswire November 7, 2025

Protalix BioTherapeutics, Inc. (PLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

ACCESS Newswire November 6, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

ACCESS Newswire November 6, 2025

Protalix BioTherapeutics to Announce Third Quarter 2025 Financial and Business Results on November 13, 2025

PR Newswire November 6, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Protalix BioTherapeutics, Inc. (PLX) Shareholders to Inquire about Securities Investigation

ACCESS Newswire November 5, 2025

PLX Investors Have Opportunity to Join Protalix BioTherapeutics, Inc. Fraud Investigation with the Schall Law Firm

GlobeNewswire November 5, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Protalix BioTherapeutics, Inc. - PLX

ACCESS Newswire November 5, 2025

Bullboard Posts (NYSEAM:PLX)

ProCell Opportunity: Protalix BioTherapeutics (NYSE American

http://beyondspx.com/2024/08/01/procell-opportunity-protalix-biotherapeutics-nyse-american-plx/
MikeTester - August 2, 2024

Interesting times

Interesting times ahead. 
ExplodeTheBank - June 15, 2023

RE:RE:Charlie

Great call on the .65 break, down to .55...we reached .57. I would guess by looking at chart .50 cents should be line in the sand.
Paparico1 - March 15, 2018

?????

Protalix: It's Time To Sell Mar. 14, 2018 10:58 AM ET | 2 comments |  About: ...
skyhigh123 - March 14, 2018

RE:Charlie

I haven't been on PLX BB for sometime but been rereading old stuff. Chart looks like it's coming to a cross road again and weekly...
Paparico1 - February 4, 2018

RE:Q3 Earnings Nov 13th

I think the earnings are on the 8th aren't they? And yes I'm pretty excited as well.
Newstockie - November 1, 2017